View in EDS HTML Full Text PDF Full Text

Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy—the MecMeth/NOA-24 trial.

Saved in:

Bibliographic Details
Title:	Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy—the MecMeth/NOA-24 trial.
Authors:	Zeyen, Thomas¹ (AUTHOR), Potthoff, Anna-Laura² (AUTHOR), Nemeth, Robert³ (AUTHOR), Heiland, Dieter H.^4,5 (AUTHOR), Burger, Michael C.⁶ (AUTHOR), Steinbach, Joachim P.⁶ (AUTHOR), Hau, Peter⁷ (AUTHOR), Tabatabai, Ghazaleh⁸ (AUTHOR), Glas, Martin⁹ (AUTHOR), Schlegel, Uwe¹⁰ (AUTHOR), Grauer, Oliver¹¹ (AUTHOR), Krex, Dietmar¹² (AUTHOR), Schnell, Oliver^4,5 (AUTHOR), Goldbrunner, Roland¹³ (AUTHOR), Sabel, Michael¹⁴ (AUTHOR), Thon, Niklas¹⁵ (AUTHOR), Delev, Daniel¹⁶ (AUTHOR), Clusmann, Hans¹⁶ (AUTHOR), Seidel, Clemens¹⁷ (AUTHOR), Güresir, Erdem² (AUTHOR)
Source:	Trials. 5/17/2022, Vol. 23 Issue 1, p1-16. 16p.
Database:	Academic Search Ultimate
Full text is not displayed to guests. Login for full access.

Be the first to leave a comment!